BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33186182)

  • 1. Malignant pleural mesothelioma: recent developments.
    Sinn K; Mosleh B; Hoda MA
    Curr Opin Oncol; 2021 Jan; 33(1):80-86. PubMed ID: 33186182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in Staging and Management of Malignant Pleural Mesothelioma.
    Wolf AS; Flores RM
    Surg Oncol Clin N Am; 2020 Oct; 29(4):603-612. PubMed ID: 32883461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current surgical strategies for malignant pleural mesothelioma.
    Takuwa T; Hasegawa S
    Surg Today; 2016 Aug; 46(8):887-94. PubMed ID: 26590581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
    Cao C; Tian D; Park J; Allan J; Pataky KA; Yan TD
    Lung Cancer; 2014 Feb; 83(2):240-5. PubMed ID: 24360321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
    Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
    In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020).
    Nadal E; Bosch-Barrera J; Cedrés S; Coves J; García-Campelo R; Guirado M; López-Castro R; Ortega AL; Vicente D; de Castro-Carpeño J
    Clin Transl Oncol; 2021 May; 23(5):980-987. PubMed ID: 33538989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.
    Song KJ; Flores RM; Wolf AS
    Thorac Surg Clin; 2020 Nov; 30(4):481-487. PubMed ID: 33012435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the Treatment of Malignant Pleural Mesothelioma.
    Janes SM; Alrifai D; Fennell DA
    N Engl J Med; 2021 Sep; 385(13):1207-1218. PubMed ID: 34551230
    [No Abstract]   [Full Text] [Related]  

  • 10. Updates in the diagnosis and treatment of malignant pleural mesothelioma.
    Katzman D; Sterman DH
    Curr Opin Pulm Med; 2018 Jul; 24(4):319-326. PubMed ID: 29553973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
    Flores RM
    Semin Thorac Cardiovasc Surg; 2009; 21(2):149-53. PubMed ID: 19822286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future developments in the management of malignant pleural mesothelioma.
    Zucali PA; De Vincenzo F; Simonelli M; Santoro A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural mesothelioma: is the surgeon still there?
    Opitz I; Weder W
    Ann Oncol; 2018 Aug; 29(8):1710-1717. PubMed ID: 29905765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.
    Schwartz RM; Lieberman-Cribbin W; Wolf A; Flores RM; Taioli E
    BMC Cancer; 2018 Nov; 18(1):1188. PubMed ID: 30497433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural mesothelioma.
    Ho L; Sugarbaker DJ; Skarin AT
    Cancer Treat Res; 2001; 105():327-73. PubMed ID: 11224994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.
    Wolf AS; Flores RM
    Thorac Surg Clin; 2016 Aug; 26(3):359-75. PubMed ID: 27427530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.